ArticleInternational journal of molecular sciences2022

Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis.

Bénédicte Oxombre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.